Access Statistics for Francis Tapon

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are You Paying Your Employees to Cheat? An Experimental Investigation 0 0 2 98 2 7 19 346
Diversification, Canadian Style: How many stocks are enough for diversifying Canadian institutional portfolios? 0 0 0 0 1 3 21 63
Equity Portfolio Diversification: How Many Stocks are Enough? Evidence from Five Developed Markets 1 2 6 111 9 52 90 484
Green as Strategy: Lessons from the Chemical Industry 0 0 0 0 0 3 9 275
How many stocks are enough for diversifying Canadian institutional portfolios? 0 0 0 24 4 5 14 111
Life after Bill C-91: Is There a Future for Canadian Generic Drug Manufacturers? 0 0 0 0 0 1 4 532
Outsourcing of Research by Pharmaceutical and Biotechnology Firms 0 0 0 0 0 2 4 1,656
Stock Return Volatility and the Current Internet Phenomenon 0 0 0 0 1 2 12 91
Testing Weak Form Efficiency on the Toronto Stock Exchange 0 0 0 91 1 3 15 416
The Creation of Competitive Advantage Through Research in the Pharmaceutical Industry: A Transaction Costs Analysis 0 0 0 0 0 2 7 887
The Impact of Risk Aversion and Stress on the Incentive Effect of Performance Pay 0 0 0 148 0 5 14 442
The number of stocks in your portfolio should be larger than you think: diversification evidence from five developed markets 0 0 2 18 3 13 29 96
What Australian investors need to know to diversity their portfolios 1 1 1 14 2 6 17 60
Total Working Papers 2 3 11 504 23 104 255 5,459
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A New Test of the Administered Pricing Hypothesis with Canadian Data 0 0 0 4 0 1 4 56
A transaction costs analysis of innovations in the organization of pharmaceutical R & D 0 0 0 76 0 1 9 190
Are You Paying Your Employees to Cheat? An Experimental Investigation 0 0 1 173 7 11 28 688
Compulsory Licensing as a Policy Instrument 0 0 0 29 0 1 5 118
Discretionary Expenditures and Profit Risk Management: The Galbraith-Caves Hypothesis 0 0 0 31 0 4 9 322
Erratum To "The Capital Asset Pricing Model: An Evaluation of Its Potential as a Strategic Planning Tool" By Thomas H. Naylor and Francis Tapon 0 0 0 3 1 2 8 26
International correlations across stock markets and industries: trends and patterns 1988-2002 0 0 0 167 4 7 18 464
Note--The Capital Asset Pricing Model and Strategic Planning: Response to Wernerfelt 0 0 0 3 0 1 1 28
Predictive blends: Fundamental Indexing meets Markowitz 0 0 2 9 1 4 10 65
Profit risk, market power and pricing decisions of large firms 0 0 0 11 0 0 5 81
Ridge Regression Estimates of the Profitability-Concentration Hypothesis: Some Canadian Evidence Revisited [Profitability and Market Structure: A Cross-Section Comparison of Canadian and American Manufacturing Industry] 0 0 0 10 0 0 4 167
Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry 0 0 0 62 0 1 9 166
Testing weak form efficiency on the Toronto Stock Exchange 0 0 1 112 1 2 11 511
The Capital Asset Pricing Model: An Evaluation of its Potential as a Strategic Planning Tool 0 0 0 13 1 3 8 72
The optimal organization of research: evidence from eight case studies of pharmaceutical firms 0 0 0 64 0 1 12 216
Um estudo da difusão do emprego de energia nuclear nos serviços industriais de utilidade pública de eletricidade nos EUA 0 0 0 2 0 2 6 22
Uncertainty, Market Structure and Performance: The Galbraith-Caves Hypothesis Revisited 0 0 0 44 0 1 4 168
Total Journal Articles 0 0 4 813 15 42 151 3,360
1 registered items for which data could not be found


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
The Impact of Risk-Aversion and Stress on the Incentive Effect of Performance-Pay 0 0 2 31 1 9 31 160
Total Chapters 0 0 2 31 1 9 31 160


Statistics updated 2026-07-10